{"entity":{"type":"insider","cik":"0001291964","url":"/insider/0001291964","json_url":"/insider/0001291964.json","name":"Berriman John E","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":2,"first":"2004-06-01","last":"2008-10-03","span_basis":"filed_date"},"name_variants":[{"name":"Berriman John E","source":"filing","n_filings":2,"first_seen":"2004-06-01","last_seen":"2008-10-03"}],"transactions":[{"id":3551046,"accession":"0001209191-08-055437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-055437","line_url":"/filing/0001209191-08-055437#line-1","is_derivative":false,"issuer_cik":"0001131907","issuer_name":"MICROMET, INC.","issuer_ticker":"MITI","issuer_name_source":null,"issuer_url":"/issuer/0001131907","owner_cik":"0001291964","owner_name":"Berriman John E","owner_url":"/insider/0001291964","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11765.0,"shares_display":"11,765","price_per_share":4.21,"price_display":"4.21","price_state":"stated","total_value":49530.65,"total_display":"49,530.65","shares_owned_after":11765.0,"shares_owned_after_display":"11,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-02","filed_date":"2008-10-03","scope":"insider"},{"id":646589,"accession":"0001209191-04-028933","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-04-028933","line_url":"/filing/0001209191-04-028933#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS INC","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291964","owner_name":"Berriman John E","owner_url":"/insider/0001291964","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":130520.0,"shares_display":"130,520","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":783120.0,"total_display":"783,120.00","shares_owned_after":155367.0,"shares_owned_after_display":"155,367","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-05-27","filed_date":"2004-06-01","scope":"insider"},{"id":646588,"accession":"0001209191-04-028933","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-04-028933","line_url":"/filing/0001209191-04-028933#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS INC","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291964","owner_name":"Berriman John E","owner_url":"/insider/0001291964","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":79673.0,"shares_display":"79,673","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":478038.0,"total_display":"478,038.00","shares_owned_after":94835.0,"shares_owned_after_display":"94,835","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-05-27","filed_date":"2004-06-01","scope":"insider"},{"id":646587,"accession":"0001209191-04-028933","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-04-028933","line_url":"/filing/0001209191-04-028933#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS INC","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291964","owner_name":"Berriman John E","owner_url":"/insider/0001291964","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":47727.0,"shares_display":"47,727","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":286362.0,"total_display":"286,362.00","shares_owned_after":56818.0,"shares_owned_after_display":"56,818","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-05-27","filed_date":"2004-06-01","scope":"insider"},{"id":646586,"accession":"0001209191-04-028933","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-04-028933","line_url":"/filing/0001209191-04-028933#line-1","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS INC","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291964","owner_name":"Berriman John E","owner_url":"/insider/0001291964","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2080.0,"shares_display":"2,080","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":12480.0,"total_display":"12,480.00","shares_owned_after":2475.0,"shares_owned_after_display":"2,475","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-05-27","filed_date":"2004-06-01","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001131907","name":"MICROMET, INC.","url":"/issuer/0001131907","role":"Director","n_filings":1,"first_seen":"2008-10-03","last_seen":"2008-10-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS INC","url":"/issuer/0001178670","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2004-06-01","last_seen":"2004-06-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001291964","retrieved_at":"2026-08-21T21:43:25+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}